6Takeda It, Haisa M, Naomoto Y, et al. Effect of 5 - fluoroura- cil on cell cycle regulatory proteins in human colon cancer cell line [J]. Jpn J Cancer Res, 1999,90:677 -684.
7Tan AR, Swain SM. Review of Flavopirid~l, a cyclin - de- pendent kinase inhibitor, as breast cancer therapy[J]. Seminars in oncology, 2002, 29 (3) : 77 - 85.
8Kononen J, Bubendorf I., Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens [J]. Nat Med, 1998,4(7) : 844-847.
9Lawrence DA, Kim D. Central/peripheral nervous system and im2-mune reponses[J]. Toxicol, 2000,142 (3) : 189-201.
10Kuss I, Hathwa YB, Ferris RL, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck [J]. Clin Cancer Res, 2004, 10 ( 11 ) :3755-3762.
2Wu P, Li S, Zhang H. Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes [J]. Drug Des Devel Ther, 2014(8): 2431-2438.
3Wang Z, Liang S, Lian X, et al. Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis [J]. Sci Rep, 2015, 30(5): 9301.
4O\'Brien M L, Vulevic B, Freer S, et al. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein [J]. J Pharmacol Exp The, 1999, 291(3): 1348-1355.
5Gyamfi M A, Ohtani II, Shinno E, et al. Inhibition of glutathione S-transferases by thonningianin A, isolated from the African medicinal herb, Thonningia sanguinea, in vitro [J]. Food Chem Toxicol, 2004, 42(9): 1401-1408.
6Abdelhamid G, El-Kadi A O. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways [J]. Free Radic Biol Med, 2015, 82: 1-12.
7Fu S M, Tu Z H, Deng L Q, et al. Induction function of siRNA-mediated survivin gene silencing on nasopharyngeal carcinoma cell apoptosis [J]. Genet Mol Res, 2015, 14(1): 2537-2545.
8Hayashi K, Tabata S, Piras V, et al. Systems biology strategy reveals PKCδ is key for sensitizing TRAIL-resistant human fibrosarcoma [J]. Front Immunol, 2015, 5: 659.
9Irie K, Yanagita R C. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin [J]. Chem Rec, 2014, 14(2): 251-267.
10Hu L, Xia L, Zhou H, et al. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620 [J]. Tumour Biol, 2013, 34(5): 2573-2581.
